Latest Quarterly Results News

Northern Star Resources has revised its FY26 all-in sustaining cost guidance upward following a downgrade in production forecasts and rising royalties, signaling tighter margins ahead.

Northern Star Resources has confirmed a downgrade to its FY26 gold production guidance following operational challenges, including a primary crusher failure and processing issues at key sites. The company affirms compliance with ASX disclosure rules and outlines the timeline of its awareness and announcements.

Regis Resources has reported a record quarterly cash and bullion build of $255 million, lifting its total cash and bullion reserves to $930 million, alongside solid gold production in the December 2025 quarter.

Ryder Capital Limited has announced a new quarterly dividend policy, declaring a fully franked 3.0 cents per share dividend to commence in January 2026, signalling a steady income stream for shareholders.

Northern Star Resources has revised down its FY26 gold production guidance following a challenging December quarter marked by equipment failures and operational disruptions across key sites.

Novatti Group has attracted a $1 million investment from Australian Wealth Advisors Group to fuel its renewed growth strategy, focusing on expanding its Acquiring business following positive early financial results.

Monadelphous Group Limited has raised its revenue guidance for 2025, buoyed by strong contract awards and elevated activity across its engineering and construction divisions.

Epsilon Healthcare has posted its highest-ever quarterly receipts of $2.919 million, reflecting a robust turnaround since exiting voluntary administration in mid-2024. The company’s strategic sale and leaseback deal has also enabled significant debt reduction, setting the stage for sustained growth.

AVITA Medical reported a 13% revenue decline in Q3 2025 but improved cash efficiency and secured Medicare payment confirmations for RECELL®, positioning for growth in 2026.

AVITA Medical reported a 13% drop in Q3 commercial revenue to $17.1 million but improved its net loss and secured CE Mark approval for RECELL GO in Europe, signaling strategic shifts ahead.

FSA Group Limited has raised its profit before tax guidance for the 2026 financial year, projecting a significant increase driven by loan growth and operational efficiencies.

Acrux Limited reports robust revenue growth in Q1 FY26, driven by strong profit share income from recently launched topical pharmaceuticals and a significant R&D tax rebate repayment.